DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cisatracurium in different doses versus atracurium during general anesthesia for abdominal surgery.

Author(s): El-Kasaby AM, Atef HM, Helmy AM, El-Nasr MA

Affiliation(s): Department of Anaesthesia, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.

Publication date & source: 2010-09, Saudi J Anaesth., 4(3):152-7.

BACKGROUND: Cisatracurium in clinical practice is devoid of histamine-induced cardiovascular effects. On the other hand, 2 ED(95) doses of cisatracurium (100 micro g/kg) do not create satisfactory intubating conditions such as those seen with equipotent doses of atracurium. The recommended intubating dose of cisatracurium is 3 ED(95). To understand this discrepancy better, we evaluated the potency and onset of atracurium and cisatracurium. MATERIALS AND METHODS: The study designed as randomized controlled clinical trial to compare between atracurium (2xED(95)) and different doses of cisatracurium (2xED(95), 4xED(95), 6xED(95)) regarding onset time, duration of action, condition of intubation, hemodynamic effects, and sings of histamine release clinically. Sixty four patients were randomly assigned to one of four groups, the first group (group 1) received 2xED(95) dose of atracurium, group 2 received 2xED(95) dose of cisatracurium, group 3 received 4xED(95) dose of cisatracurium, while group 4 received 6xED(95) dose of cisatracurium. The Datex relaxograph (Type NMT-100-23-01, S/N: 37541) for neuromuscular monitoring was used. RESULTS: HR, MABP was statistically significant increased post-intubation with administration of 2xED(95) dose of atracurium in group 1 and the same dose of cisatracurium in group 2 but 5-20 min later was not statistically significant with administration of 4xED(95) and 6xED(95) doses of cisatracurium in groups 3 and 4, respectively. Onset time was found to be significantly lower with 2xED(95) dose of atracurium than with the same dose of cisatracurium. At the same time, higher doses of cisatracurium (4xED(95) and 6xED(95)) showed onset time and longer duration of action that was significantly lower than with atracurium and with lower dose of cisatracurium (2xED(95)). Only 6xED(95) dose of cisatracurium showed statistically significant difference versus the atracurium dose with higher percentages of patients with excellent condition of intubation. 4xED(95) and 6xED(95) doses of cisatracurium were significantly better than 2xED(95) dose of cisatracurium. 2xED(95) dose of atracurium and 2xED(95) dose of cisatracurium were similar, while 4xED(95) and 6xED(95) doses of cisatracurium were significantly better than atracurium and 2xED(95) dose of cisatracurium. CONCLUSION: The same dose (2xED(95) dose) atracurium is more effective neuromuscular blocking agent than cisatracurium, while higher doses of cisatracurium 4xED(95) and 6xED(95) provide more effective, more rapid neuromuscular blocking with longer duration of action, stable hemodynamic status, and no associated signs of histamine release clinically.

Page last updated: 2011-12-09

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017